Business Development

Adamed has gone international

Adamed joined the globalinnovation race in the early 2000s and has consistently strengthened its position on international markets. Now Adamed is a truly international organization, with almost 2,200 staff in 9 countries. 

 

We sell our products B2B on 70 markets worldwide, and our product portfolio includes over 500 brands. We sell our products in two business models:

Out-licensing to our business partners, where the intellectual property rights to the products remain in Poland.
Building our own sales and marketing channels, while at the same time promoting the Adamed brand in new countries.

 

License-out

The Adamed Business Development Team is a group of professionals responsible for the sale of Adamed products on global markets.

We are open to different business partnership models, including out-licensing, product distribution, joint development of new products, and contract manufacturing.

We provide comprehensive support on regulatory and intellectual property matters, market entry strategy for offered products, and open partnership. All of these aspects are aimed at ensuring that all new products are successfully launched with minimal risk while maintaining competitive prices for our customers.

Our business partners are provided with a registration dossier for all finished formulations in e-CTD format that meets the most stringent requirements of the national regulatory agencies in their respective countries, including the requirements for stability testing for all climate zones. Our products are manufactured at state-of-the-art facilities certified for compliance with GMP standards, both European and those applicable in other countries, including Saudi Arabia, Turkey, and Australia. Having vast experience in business development and out-licensing, the team establishes top-level partnerships based on a win-win strategy as a guarantee for long-lasting, stable cooperation with our business partners based on mutual trust.

Oncology
  • Abiraterone250mg, 500mg tablets
  • Bortezomib3.5mg vial
  • ImatinibMesylate 100mg, 400mg capsules 
  • Sunitinib12.5mg; 25mg; 37.5mg; 50mg capsules 
Cardiology & Diabetology
  • Amlodipine Besylate5mg; 10mg tablets
  • Amlodipine Besylate5mg; 10mg, orodispersible tablets 
  • Candesartan + Amlodipine Besylate8mg/5mg; 8mg/10mg; 16mg/5mg; 16mg/10mg capsules
  • Cilostazol50mg; 100mg tablets 
  • Clopidogrel Bisulfate75mg tablets
  • Eplerenone 25mg; 50mg tablets
  • Ezetimibe 10mg tablets 
  • Ezetimibe + Rosuvastatin Calcium 10mg/5mg; 10mg/10mg; 10mg/20mg tablets 
  • Perindopril + Amlodipine Besylate4mg/5mg; 4mg/10mg; 8mg/5mg; 8mg/10mg tablets
  • Ramipril + Amlodipine Besylate2.5mg/5mg; 5mg/5mg; 5mg/10mg; 10mg/5mg; 10mg/10mg capsules
  • Ramipril + Amlodipine Besylate + HCTZ5mg/5mg/25mg; 5mg/10mg/25mg; 10mg/5mg/25mg; 5mg/5mg/12.5mg; 10mg/10mg/25mg; 2.5mg/5mg/12.5mg capsules
  • Ramipril + Bisoprolol2.5mg/1.25mg; 2.5mg/2.5mg, 5mg/2.5mg; 5mg/5mg; 10mg/5mg; 10mg/10mg; capsules
  • Ranolazine375mg, 500mg, 750mg; prolonged-release tablets
  • Rivaroxaban 2.5mg; 10mg; 15mg; 20mg, film-coated tablets
  • Rosuvastatin Calcium 5mg; 10mg; 15mg; 20mg; 30mg; 40mg tablets 
  • Rosuvastatin calcium + Amlodipine Besylate10mg/5mg; 10mg/10mg; 20mg/5mg; 20mg/10mg capsules
  • Rosuvastatin Calcium + ASA 5mg/100mg; 10mg/100mg; 20mg/100mg capsules
  • Sitagliptin25mg; 50mg; 100mg, film-coated tablets
  • Sitagliptin + Metformin XR50mg/500mg, 50mg/1,000mg, 100mg/1,000mg, prolonged-release tablets
Central nervous system
  • Duloxetine 30mg; 60mg film-coated gastro-resistant tablets
  • Mianserin Hydrochloride 60mg film-coated tablets
  • Olanzapine 5mg; 10mg tablets
  • Olanzapine ODT5mg; 10mg; 15mg; 20mg, orodispersible tablets
  • Pregabalin25mg; 50mg; 75mg; 100mg; 150mg; 200mg; 225mg; 300mg capsules
Pulmonology & Allergology
  • Levocetirizinedihydrochloride5mg film-coated tablets
  • Levocetirizinedihydrochloride0.5mg/ml oral solution 
  • Tiotropium 18mcg; capsules (inhaler available)
Gynaecology & Urology
  • Progesterone 50mg, 100mg, 200mg vaginal tablets
  • Tamsulosin OCAS 0.4mg ER tablets
  • Solifenacin + Tamsulosin 6 mg/0.4 mg two-layer coated tablet
Other therapeutic areas
  • Azithromycin 250mg; 500mg, film-coated tablets
  • Dexamethasone 4mg; 8mg; 20mg chewable tablets
  • Fludrocortisone 0.1 mg tablets
  • Naproxen EC mg 500mg gastro-resistant tablets
  • Risedronate Sodium 35mg; 75mg, film-coated tablets
Over-the-counter medicines (as per the Polish classification)
  • Acyclovir 200mg tablets
  • Cytisine1.5mg film-coated tablets 
  • Dimenhydrinate50mg chewable tablets
  • Drotaverine + Metamizole + Caffeine 40mg/400mg/60mg; 80mg/400mg/60mg tablets 
  • Furazidin50mg100mg tablets (also available as RX)
  • Hymecromone400mg tablets
  • Metamizole500mg tablets
  • Naproxen 220mg capsules
  • OctenidineDihydrochloride/Phenoxyethanol (1 mg + 20mg)/1 g solution for cutaneous use
  • Paracetamolum + Propyphenazone + Caffeine 250mg/150mg/50mg tablets
  • Simethicone 240mg capsules
  • Zinc Oxide Spray 16%; 17%/ml 

In-Licensing & Business Development Department

Sylwia Berdzik-Kalarus
Business Development and Portfolio Management Director
sylwia.berdzik@adamed.com

Out-Licensing Department 


Sebastian Gromek
Director Licensing-Out & Commercial Alliances Management
sebastian.gromek@adamed.com